These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 31237329)

  • 1. The CRISP-P study: feasibility of a self-completed colorectal cancer risk prediction tool in primary care.
    Harty EC; McIntosh JG; Bickerstaffe A; Hewabandu N; Emery JD
    Fam Pract; 2019 Nov; 36(6):730-735. PubMed ID: 31237329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care.
    Walker JG; Bickerstaffe A; Hewabandu N; Maddumarachchi S; Dowty JG; ; Jenkins M; Pirotta M; Walter FM; Emery JD
    BMC Med Inform Decis Mak; 2017 Jan; 17(1):13. PubMed ID: 28103848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.
    Walker JG; Macrae F; Winship I; Oberoi J; Saya S; Milton S; Bickerstaffe A; Dowty JG; De Abreu Lourenço R; Clark M; Galloway L; Fishman G; Walter FM; Flander L; Chondros P; Ait Ouakrim D; Pirotta M; Trevena L; Jenkins MA; Emery JD
    Trials; 2018 Jul; 19(1):397. PubMed ID: 30045764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring a novel method for optimising the implementation of a colorectal cancer risk prediction tool into primary care: a qualitative study.
    Milton S; Emery JD; Rinaldi J; Kinder J; Bickerstaffe A; Saya S; Jenkins MA; McIntosh J
    Implement Sci; 2022 May; 17(1):31. PubMed ID: 35550164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using an electronic self-completion tool to identify patients at increased risk of melanoma in Australian primary care.
    Habgood E; Walter FM; O'Hare E; McIntosh J; McCormack C; Emery JD
    Australas J Dermatol; 2020 Aug; 61(3):231-236. PubMed ID: 32050041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Genomic Test for Colorectal Cancer Risk: Is This Acceptable and Feasible in Primary Care?
    Saya S; McIntosh JG; Winship IM; Clendenning M; Milton S; Oberoi J; Dowty JG; Buchanan DD; Jenkins MA; Emery JD
    Public Health Genomics; 2020; 23(3-4):110-121. PubMed ID: 32688362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial.
    Wu RR; Orlando LA; Himmel TL; Buchanan AH; Powell KP; Hauser ER; Agbaje AB; Henrich VC; Ginsburg GS
    BMC Fam Pract; 2013 Aug; 14():111. PubMed ID: 23915256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CRISP-Q study: Communicating the risks and benefits of colorectal cancer screening.
    Kim GY; Walker JG; Bickerstaffe A; Hewabandu N; Pirotta M; Flander L; Jenkins M; Emery JD
    Aust J Gen Pract; 2018 Mar; 47(3):139-145. PubMed ID: 29621846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening.
    Emery JD; Jenkins MA; Saya S; Chondros P; Oberoi J; Milton S; Novy K; Habgood E; Karnchanachari N; Pirotta M; Trevena L; Bickerstaffe A; De Abreu Lourenço R; Crothers A; Ouakrim DA; Flander L; Dowty JG; Walter FM; Clark M; Doncovio S; Etemadmoghadam D; Fishman G; Macrae F; Winship I; McIntosh JG
    Br J Gen Pract; 2023 Aug; 73(733):e556-e565. PubMed ID: 37012077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of patients at risk for colorectal cancer in primary care: an explorative study with routine healthcare data.
    Koning NR; Moons LM; Büchner FL; Helsper CW; Ten Teije A; Numans ME
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1443-8. PubMed ID: 26398457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of family history of colorectal cancer in primary care: perceptions of first degree relatives of people with colorectal cancer.
    Cameron E; Rose S; Carey M
    Patient Educ Couns; 2014 Mar; 94(3):427-31. PubMed ID: 24380670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
    Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
    Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness of Stomach and Colorectal Cancer Risk Factors, Symptoms and Time Taken to Seek Medical Help Among Public Attending Primary Care Setting in Muscat Governorate, Oman.
    Al-Azri M; Al-Kindi J; Al-Harthi T; Al-Dahri M; Panchatcharam SM; Al-Maniri A
    J Cancer Educ; 2019 Jun; 34(3):423-434. PubMed ID: 28782080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of FOB testing in eastern-Australian general practice patients: what has a national bowel cancer screening program delivered?
    Paul CL; Carey ML; Russell G; D'Este C; Sanson-Fisher RW; Zwar N
    Health Promot J Austr; 2015 Apr; 26(1):39-44. PubMed ID: 25818504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of storytelling compared to a personal risk tool intervention on colorectal cancer screening in low-income patients.
    Larkey LK; McClain D; Roe DJ; Hector RD; Lopez AM; Sillanpaa B; Gonzalez J
    Am J Health Promot; 2015; 30(2):e59-70. PubMed ID: 25615708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trial of a self-assessment tool of problems following treatment of colorectal cancer: a prospective study in Australia primary care.
    Ngune I; Jiwa M; McManus A; Parsons R; Hodder R
    Eur J Cancer Care (Engl); 2016 Jan; 25(1):69-78. PubMed ID: 26094837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history in colonoscopy patients: feasibility and performance of electronic and paper-based surveys for colorectal cancer risk assessment in the outpatient setting.
    Guivatchian T; Koeppe ES; Baker JR; Moisa C; Demerath M; Foor-Pessin C; Chey WD; Eswaran SL; Kolars JC; Menees SB; Rajala M; Rice MD; Rizk R; Rubenstein JH; Sharma P; Todisco A; Stoffel EM
    Gastrointest Endosc; 2017 Oct; 86(4):684-691. PubMed ID: 28174125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of primary care physician counseling on participation rate and use of sedation in colonoscopy-based colorectal cancer screening program--a randomized controlled study.
    Boguradzka A; Wiszniewski M; Kaminski MF; Kraszewska E; Mazurczak-Pluta T; Rzewuska D; Ptasinski A; Regula J
    Scand J Gastroenterol; 2014 Jul; 49(7):878-84. PubMed ID: 24797871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
    Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
    BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool.
    Ladabaum U; Patel A; Mannalithara A; Sundaram V; Mitani A; Desai M
    Cancer; 2016 Sep; 122(17):2663-70. PubMed ID: 27219715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.